Emerging disease-modifying therapies in multiple sclerosis.

Emerging disease-modifying therapies in multiple sclerosis.

Item
http://www.wikidata.org/entity/Q37994555
Review of daclizumab and its therapeutic potential in the treatment of relapsing-remitting multiple sclerosisComparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosisFingolimod and cardiac risk: latest findings and clinical implicationsPreferred features of oral treatments and predictors of non-adherence: two web-based choice experiments in multiple sclerosis patients.Microglial activation and antioxidant responses induced by the Parkinson's disease protein α-synuclein.Potential of urinary metabolites for diagnosing multiple sclerosisMultiple sclerosis: individualized disease susceptibility and therapy response.Incidence and mitigation of gastrointestinal events in patients with relapsing-remitting multiple sclerosis receiving delayed-release dimethyl fumarate: a German phase IV study (TOLERATE).
P2860

Emerging disease-modifying therapies in multiple sclerosis.

Item
http://www.wikidata.org/entity/Q37994555
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Emerging disease-modifying therapies in multiple sclerosis.
@en
Emerging disease-modifying therapies in multiple sclerosis.
@nl
type
label
Emerging disease-modifying therapies in multiple sclerosis.
@en
Emerging disease-modifying therapies in multiple sclerosis.
@nl
prefLabel
Emerging disease-modifying therapies in multiple sclerosis.
@en
Emerging disease-modifying therapies in multiple sclerosis.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Emerging disease-modifying therapies in multiple sclerosis.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P921